Status: Recruiting
Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis
The purpose of this study is to determine if nicotinamide in combination with bedaquiline, pretomanid, and linezolid, is safe and effective in treating drug-susceptible pulmonary tuberculosis.
Participants needed: 165
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Gates Medical Research InstituteUpdated: Jul 2, 2026Locations: 4
Eligibility criteria
Age 18-65 years at consent [+10]
Prior TB within 3 years, >1 prior episode, or anti-TB treatment within 60 days [+10]